Global Parkinson'S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%. Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period. However, availability of other treatments is hindering the market growth.

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment. Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period. This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited.

Therapeutic Class:
• Monoamine oxidase B inhibitors (MAO-B inhibitors)
• Dopamine precursors
• Dopamine agonists (non-ergoline)
• Catechol-O-methyl transferase (COMT) inhibitors
• Carbidopa/Levodopa
• Other Therapeutic Classes

Medical Devices:
• Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
• Deep Brain Stimulation (DBS) Devices

Patient Care Setting:
• Hospitals
• Clinics

Distribution Channel:
• Retail pharmacies
• Online pharmacies
• Hospital pharmacies
• Drug stores

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements